共 10 条
- [1] Development and Seroconversion of Anti-Cytolethal Distending Toxin(CdtB) and Anti-Vinculin Antibodies in a Patient with Evolving Post-infectious IBS [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S807 - S807
- [2] Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome [J]. Digestive Diseases and Sciences, 2017, 62 : 1480 - 1485
- [6] Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10
- [8] ESTIMATING DIAGNOSTIC COSTS ASSOCIATED WITH A SECOND-GENERATION BLOOD TEST FOR ANTI-VINCULIN AND ANTI-CYTOLETHAL DISTENDING TOXIN B (CDTB) BIOMARKERS IN COMPARISON TO THE STANDARD EXCLUSIONARY APPROACH FOR IRRITABLE BOWEL SYNDROME WITH A DIARRHEAL COMPONENT (IBS-D/M) [J]. VALUE IN HEALTH, 2020, 23 : S146 - S146
- [10] ANTIBODIES TO VINCULIN AND CYTOLETHAL DISTENDING TOXIN B (IBSCHEK) ARE ASSOCIATED WITH A POST-INFECTIOUS AETIOLOGY IN PATIENTS WITH MIXED BOWEL HABIT IBS BUT NOT SMALL INTESTINAL BACTERIAL OVERGROWTH, QUALITY OF LIFE OR CHANGES IN GASTROINTESTINAL MOTILITY [J]. GASTROENTEROLOGY, 2017, 152 (05) : S718 - S719